Determinants of short- and long-term outcome in patients with respiratory failure caused by AIDS-related Pneumocystis carinii pneumonia

被引:28
作者
Forrest, DM
Zala, C
Djurdjev, O
Singer, J
Craib, KJP
Lawson, L
Russell, JA
Montaner, JSG
机构
[1] St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada
[2] St Pauls Hosp, Dept Hlth Care & Epidemiol, Vancouver, BC V6Z 1Y6, Canada
[3] St Pauls Hosp, Dept Med, Vancouver, BC V6Z 1Y6, Canada
[4] Univ British Columbia, Div Crit Care Med, Vancouver, BC V5Z 1M9, Canada
[5] Univ British Columbia, Div Resp Med, Vancouver, BC V5Z 1M9, Canada
[6] Univ British Columbia, Fac Med, Vancouver, BC V5Z 1M9, Canada
[7] Canadian HIV Trials Network, Vancouver, BC, Canada
关键词
D O I
10.1001/archinte.159.7.741
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To determine (1) predictors of in-hospital mortality and long-term survival in patients with acute respiratory failure (ARF) caused by acquired immunodeficiency syndrome-related Pneumocystis carinii pneumonia (PCP) and (2) long-term survival for patients with ARF relative to those without ARF. Methods: A retrospective medical chart review was conducted of all cases of PCP-related ARF for which the patient was admitted to the intensive care unit of a single tertiary care institution between 1991 and 1996. Data were extracted regarding physiologic scores, relevant laboratory values, and duration of previous maximal therapy with combined anti-PCP agents and corticosteroids at entry to the intensive care unit. Duration of survival was determined by Kaplan-Meier methods from date of first hospital admission and compared for patients with and without ARF. Results: There were 41 admissions to the intensive care unit among 39 patients, with 56.4% in-hospital mortality. Higher physiologic scores (Acute Physiology and Chronic Health Evaluation II [APACHE II]. Acute Lung Injury, and modified Multisystem Organ Failure scores) were predictive of in-hospital mortality. Duration of previous maximal therapy also predicted in-hospital mortality (45% for patients with <5 days of previous maximal therapy vs 88% for those with greater than or equal to 5 days of previous maximal therapy; P = .03). Combining physiologic scores and duration of previous maximal therapy enhanced prediction of in-hospital mortality. There was no difference in long-term survival between patients with PCP with ARF and those without ARF (P = .80), and baseline characteristics did not predict long-term survival. Conclusions: In-hospital mortality of patients with acquired immunodeficiency syndrome-related PCP and ARF is predicted by duration of previous maximal therapy and physiologic scores, and their combination enhances predictive accuracy. Long-term survival of patients with ARF caused by PCP is comparable to that of patients with PCP who do not develop ARF, and determinants of in-hospital mortality do not predict longterm survival.
引用
收藏
页码:741 / 747
页数:7
相关论文
共 52 条
[1]  
ARCHIBALD C, 1997, 6 ANN CAN ASS HIV RE
[2]  
BENFIELD TL, 1995, AM J RESP CRIT CARE, V151, P1058
[3]   A RAPID PREADMISSION METHOD FOR PREDICTING INPATIENT COURSE OF DISEASE FOR PATIENTS WITH HIV-RELATED PNEUMOCYSTIS-CARINII PNEUMONIA [J].
BENNETT, CL ;
WEINSTEIN, RA ;
SHAPIRO, MF ;
KESSLER, HA ;
DICKINSON, GM ;
PETERSON, B ;
COHN, SE ;
GEORGE, WL ;
GILMAN, SC .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 150 (06) :1503-1507
[4]   COMBINED APACHE-II SCORE AND SERUM LACTATE-DEHYDROGENASE AS PREDICTORS OF IN-HOSPITAL MORTALITY CAUSED BY 1ST EPISODE PNEUMOCYSTIS-CARINII PNEUMONIA IN PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].
BENSON, CA ;
SPEAR, J ;
HINES, D ;
POTTAGE, JC ;
KESSLER, HA ;
TRENHOLME, GM .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (02) :319-323
[5]   THE EFFECTS OF VASODILATION WITH PROSTACYCLIN ON OXYGEN DELIVERY AND UPTAKE IN CRITICALLY ILL PATIENTS [J].
BIHARI, D ;
SMITHIES, M ;
GIMSON, A ;
TINKER, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (07) :397-403
[6]   A CONTROLLED TRIAL OF EARLY ADJUNCTIVE TREATMENT WITH CORTICOSTEROIDS FOR PNEUMOCYSTIS-CARINII PNEUMONIA IN THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].
BOZZETTE, SA ;
SATTLER, FR ;
CHIU, J ;
WU, AW ;
GLUCKSTEIN, D ;
KEMPER, C ;
BARTOK, A ;
NIOSI, J ;
ABRAMSON, I ;
COFFMAN, J ;
HUGHLETT, C ;
LOYA, R ;
CASSENS, B ;
AKIL, B ;
MENG, TC ;
BOYLEN, CT ;
NIELSEN, D ;
RICHMAN, DD ;
TILLES, JG ;
LEEDOM, J ;
MCCUTCHAN, JA .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (21) :1451-1457
[7]   PROGNOSTIC FACTORS AND LIFE EXPECTANCY OF PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME AND PNEUMOCYSTIS-CARINII PNEUMONIA [J].
BRENNER, M ;
OGNIBENE, FP ;
LACK, EE ;
SIMMONS, JT ;
SUFFREDINI, AF ;
LANE, HC ;
FAUCI, AS ;
PARRILLO, JE ;
SHELHAMER, JH ;
MASUR, H .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1987, 136 (05) :1199-1206
[8]   ACUTE RESPIRATORY-FAILURE DUE TO PNEUMOCYSTIS-CARINII PNEUMONIA [J].
BROOKS, KR ;
ONG, R ;
SPECTOR, RS ;
GREENBAUM, DM .
CRITICAL CARE CLINICS, 1993, 9 (01) :31-48
[9]   PREDICTING SURVIVAL IN AIDS PATIENTS WITH RESPIRATORY-FAILURE - APPLICATION OF THE APACHE-II SCORING SYSTEM [J].
CHU, DY .
CRITICAL CARE CLINICS, 1993, 9 (01) :89-105
[10]   CHANGING USE OF INTENSIVE-CARE FOR HIV-INFECTED PATIENTS WITH PNEUMOCYSTIS-CARINII PNEUMONIA [J].
CURTIS, JR ;
GREENBERG, DL ;
HUDSON, LD ;
FISHER, LD ;
KRONE, MR ;
COLLIER, AC .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 150 (05) :1305-1310